ATNAAAntidote Treatment-Nerve Agent Autoinjector
References in periodicals archive ?
The ATNAA utilizes Meridian's patented multichambered auto-injector technology and delivers two antidotes in a single injection while maintaining separation of the two drugs in both the injector and at the injection site.
The ATNAA introduces significant advantages over previous technology, including greater speed of administration, easier use and reduced size and weight for improved logistics and mobility," said James H.
The ATNAA uses multichambered auto-injector technology to deliver two antidotes in a single injection while keeping the two drugs separate in the injector.
The ATNAA enjoys significant advancements over the auto-injectors currently used by U.